Search the Exchange

Rare Renal Disorders

Explore facts and recommendations for pharmacological treatments for rare renal disorders.

pharmacotherapies
Filters

We are still gathering material for this library.

Please check again soon.

We're sorry

We didn't find any resources that match your selection.

Please adjust your filter(s) and try again.

pharmacotherapies
 
Preview
PDF

PHYOX Clinical Development Program

An overview of the PHYOX clinical development program evaluating nedosiran for the treatment of primary hyperoxaluria.

Download
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
pharmacotherapies
 
Preview
PDF

PHYOX2 infographic

This infographic provides an overview of PHYOX2, the pivotal randomized study of nedosiran in PH1 or PH2

Download
Share
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
continuing education icon

Continuing Education

Find accredited opportunities in rare renal disorders education.

Explore CE Activities

Rare Renal Disorders

congress materials
View Resources

Rare Renal Disorders

disease education
View Resources

Looking for additional resources?
Explore other libraries or search the Exchange.

Disease Education | Congress Materials

Additional Information

speak to a live medical representative icon

Speak to a live medical representative.

If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.

Start Conversation
search the medical information database icon

Search the Medical Information Database

The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.

Begin Search
Novo Nordisk® Scientific Exchange logo

Scientific Exchange is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.

© 2022 Novo Nordisk All rights reserved.

Novo Nordisk Scientific Exchange provides Healthcare Professionals with accurate and balanced evidence-based information about products, disease states, and more. This website is a scientific resource for U.S. Healthcare Professionals to research therapeutic areas, search our medical information database, submit questions, or speak with Novo Nordisk U.S. Healthcare Professionals. The information provided is for educational purposes only and is not intended to promote any products.

 

Please click “Continue” to confirm you are a U.S. Healthcare Professional.

This medical content was developed independently by a third party via an educational grant. This material is copyright protected and is provided here with permission for educational and informational purposes only and is not certified for continuing education credits.

Continue

You are now leaving the Novo Nordisk Scientific Exchange website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

Continue

GATED INTERSTITAL  

You are now leaving the Novo Nordisk Scientific Exchange website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

Access Resources

ACCESS DENIED

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.